HomeCompareYUKA vs JNJ

YUKA vs JNJ: Dividend Comparison 2026

YUKA yields 3447.68% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YUKA wins by $1718725853440.93M in total portfolio value
10 years
YUKA
YUKA
● Live price
3447.68%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1718725853440.96M
Annual income
$1,625,953,460,796,599,600.00
Full YUKA calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — YUKA vs JNJ

📍 YUKA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYUKAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YUKA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YUKA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YUKA
Annual income on $10K today (after 15% tax)
$293,052.92/yr
After 10yr DRIP, annual income (after tax)
$1,382,060,441,677,109,500.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, YUKA beats the other by $1,382,060,441,677,105,400.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YUKA + JNJ for your $10,000?

YUKA: 50%JNJ: 50%
100% JNJ50/50100% YUKA
Portfolio after 10yr
$859362926720.50M
Annual income
$812,976,730,398,302,100.00/yr
Blended yield
94.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

YUKA
No analyst data
Altman Z
-12.0
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YUKA buys
0
JNJ buys
0
No recent congressional trades found for YUKA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYUKAJNJ
Forward yield3447.68%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1718725853440.96M$30.3K
Annual income after 10y$1,625,953,460,796,599,600.00$4,689.40
Total dividends collected$1712356187345.74M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: YUKA vs JNJ ($10,000, DRIP)

YearYUKA PortfolioYUKA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$355,468$344,768.14$10,592$272.30+$344.9KYUKA
2$11,834,004$11,453,653.44$11,289$357.73+$11.82MYUKA
3$369,024,312$356,361,927.83$12,123$472.89+$369.01MYUKA
4$10,780,436,528$10,385,580,513.96$13,141$629.86+$10780.42MYUKA
5$295,084,227,962$283,549,160,877.14$14,408$846.81+$295084.21MYUKA
6$7,569,350,753,840$7,253,610,629,920.26$16,021$1,151.60+$7569350.74MYUKA
7$181,992,603,484,888$173,893,398,178,279.50$18,122$1,588.22+$181992603.47MYUKA
8$4,102,191,035,741,551$3,907,458,950,012,720.50$20,930$2,228.20+$4102191035.72MYUKA
9$86,703,170,695,665,170$82,313,826,287,421,710.00$24,792$3,191.91+$86703170695.64MYUKA
10$1,718,725,853,440,961,300$1,625,953,460,796,599,600.00$30,274$4,689.40+$1718725853440.93MYUKA

YUKA vs JNJ: Complete Analysis 2026

YUKAStock

Yuka Group, Inc., through its subsidiary, Yuka Clothing, Inc., operates as an e-commerce company in the United States. The company focuses on the provision of brand building and sales-and-marketing services to its customers with focus on online and TV promotional sales. Its products include gourmet food, pet products, accessories, art, sports and outdoors, apparel, beauty, kids, home, electronics, and health and wellness products. The company was formerly known as Grand Capital Ventures, Inc. and changed its name to Yuka Group, Inc. in August 2020. Yuka Group, Inc. was incorporated in 1991 and is based in North Miami, Florida.

Full YUKA Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this YUKA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YUKA vs SCHDYUKA vs JEPIYUKA vs OYUKA vs KOYUKA vs MAINYUKA vs ABBVYUKA vs MRKYUKA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.